June 15 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Filed clinical trial application with health canada
* Filed cta for a proof of concept clinical study for its long-acting transdermal anti-nausea patch, aqs1303
* Approval of cta is expected in early july Source text for Eikon: ID:nMKWrjsTCa Further company coverage: AQS.V